554 related articles for article (PubMed ID: 28771276)
1. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody against integrin α
Zeng DF; Chen F; Wang S; Chen SL; Xu Y; Shen MQ; Du CH; Wang C; Kong PY; Cheng TM; Su YP; Wang JP
J Thromb Haemost; 2018 Sep; 16(9):1843-1856. PubMed ID: 29953749
[TBL] [Abstract][Full Text] [Related]
3. Decreased cyclooxygenase-2 associated with impaired megakaryopoiesis and thrombopoiesis in primary immune thrombocytopenia.
Zhuang X; Xu P; Ou Y; Shao X; Li Y; Ma Y; Qin S; Hua F; Zhan Y; Ji L; Qiao T; Chen H; Cheng Y
J Transl Med; 2023 Aug; 21(1):540. PubMed ID: 37573325
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
5. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
6. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
[TBL] [Abstract][Full Text] [Related]
7. Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis Pathway.
Miao W; Song B; Shi B; Wan Q; Lv Q; Chen H; Zhu M; Zhang L; Han Y; Wu D
Thromb Haemost; 2021 Apr; 121(4):495-505. PubMed ID: 33124021
[TBL] [Abstract][Full Text] [Related]
8. Novel Murine Model of Immune Thrombocytopaenia through Immunized CD41 Knockout Mice.
Li X; Wang SW; Feng Q; Hou Y; Lu N; Ma CH; Gao CJ; Hou M; Peng J
Thromb Haemost; 2019 Mar; 119(3):377-383. PubMed ID: 30630213
[TBL] [Abstract][Full Text] [Related]
9. Neonatal mice with necrotizing enterocolitis-like injury develop thrombocytopenia despite increased megakaryopoiesis.
Namachivayam K; MohanKumar K; Garg L; Torres BA; Maheshwari A
Pediatr Res; 2017 May; 81(5):817-824. PubMed ID: 28085792
[TBL] [Abstract][Full Text] [Related]
10. Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.
Arnold DM; Nazi I; Toltl LJ; Ross C; Ivetic N; Smith JW; Liu Y; Kelton JG
Eur J Haematol; 2015 Dec; 95(6):532-7. PubMed ID: 25684257
[TBL] [Abstract][Full Text] [Related]
11. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients.
Ma L; Zhou Z; Zhang D; Yang S; Wang J; Xue F; Yang Y; Yang R
Thromb Haemost; 2012 May; 107(5):937-50. PubMed ID: 22398715
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocyte apoptosis in immune thrombocytopenia.
Vrbensky JR; Nazy I; Toltl LJ; Ross C; Ivetic N; Smith JW; Kelton JG; Arnold DM
Platelets; 2018 Nov; 29(7):729-732. PubMed ID: 29787328
[TBL] [Abstract][Full Text] [Related]
14. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.
McMillan R; Wang L; Tomer A; Nichol J; Pistillo J
Blood; 2004 Feb; 103(4):1364-9. PubMed ID: 14576051
[TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.
Chang M; Nakagawa PA; Williams SA; Schwartz MR; Imfeld KL; Buzby JS; Nugent DJ
Blood; 2003 Aug; 102(3):887-95. PubMed ID: 12676790
[TBL] [Abstract][Full Text] [Related]
16. Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.
Rivière É; Viallard JF; Guy A; Kilani B; Vieira-Dias J; Pons AC; Couffinhal T; Pellegrin JL; James C
Br J Haematol; 2015 Aug; 170(3):408-15. PubMed ID: 25873418
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis.
Wang Q; You T; Fan H; Wang Y; Chu T; Poncz M; Zhu L
Platelets; 2017 Jan; 28(1):82-89. PubMed ID: 27534900
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
Gernsheimer T
Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
[TBL] [Abstract][Full Text] [Related]
19. Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.
Feng X; Scheinberg P; Samsel L; Rios O; Chen J; McCoy JP; Ghanima W; Bussel JB; Young NS
J Thromb Haemost; 2012 Aug; 10(8):1616-23. PubMed ID: 22537155
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
